1310875-94-5

Basic information

• Product Name: 4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-4-oxobut-2-enoic acid
• Synonyms: 4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-4-oxobut-2-enoic acid
• CAS NO: 1310875-94-5
• Molecular Weight: 443.379
• Mol File: 1310875-94-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-4-oxobut-2-enoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-4-oxobut-2-enoic acid(1310875-94-5)
• EPA Substance Registry System: 4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-4-oxobut-2-enoic acid(1310875-94-5)

Safety Data

• Hazardous Substances Data: 1310875-94-5(Hazardous Substances Data)

Upstream product

• 1338973-20-8 3-bromo-5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-pyridin-2(1H)-one 
• 1338973-22-0 5-(2,4-difluorobenzyl)-3-bromopyridin-2(1H)-one 
• 1310875-96-7 5-(2,4-difluorobenzyl)pyridin-2(1H)-one 
• 1310875-95-6 (2,4-difluorophenyl)(6-methoxypyridin-3-yl)methanol 
• 1310876-00-6 methyl 4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-4-oxobut-2-enoate 
• 1310875-99-0 3-acetyl-5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)pyridin-2(1H)-one 
• 1310875-98-9 5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-3-iodopyridin-2(1H)-one 
• 1310875-97-8 5-(2,4-difluorobenzyl)-3-iodopyridin-2(1H)-one 
• 13472-85-0 2-methoxy-5-bromopyridine 
• 1550-35-2 2,4-difluorobenzaldehyde 

Downstream Products

• 1310876-01-7 (1S,2S)-4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-N-(2-hydroxycyclopentyl)-4-oxobut-2-enamide 
• 1310876-08-4 4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-4-oxo-N-(2-oxopyrrolidin-1-yl)but-2-enamide 
• 1338973-31-1 isopropyl 4-(5-(2,4-difluorobenzyl)-1-(2-fluorobenzyl)-2-oxo-1,2-dihydropyridin-3-yl)-2-hydroxy-4-oxobut-2-enoate 

Relevant articles and documents

Discovery of a potent HIV integrase inhibitor that leads to a prodrug with significant anti-HIV activity

Worldwide research efforts in drug discovery involving HIV integrase have produced only one compound, raltegravir, that has been approved for clinical use in HIV/AIDS. As resistance, toxicity, and drug-drug interactions are recurring issues with all class